NEJM (@NEJM) header
NEJM (@NEJM) profile picture

The New England Journal of Medicine is the world’s leading medical journal and website.

Boston, MA
Joined March 2009
Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)
Pinned Tweet
𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection is an infectious disease, and treatment regimens should ideally be guided by antimicrobial-susceptibility testing whenever possible. 🔗 nej.md/4Bj3O58 Both phenotypic (culture-based) and molecular methods of antimicrobial-susceptibility testing are available (seen in figure). Culture-based testing remains the reference standard because it is the only method that can ascertain the susceptibility of isolates to all antibiotics commonly used for eradication. Molecular antimicrobial-susceptibility testing offers greater efficiency than culture-based testing by eliminating the need for 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 culture. Molecular-based testing can be conducted with fresh or formalin-fixed gastric-tissue samples (used for histopathological examination) and successfully cultured isolates. More recently, gastric-fluid samples obtained from a swallowed gastric string have emerged as a cost-effective alternative culture-based testing method. Stool-based molecular antimicrobial-susceptibility testing is now available, which avoids invasive endoscopy. Commercial polymerase-chain-reaction–based kits are now available for identifying 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 resistance to clarithromycin and levofloxacin by detecting specific mutations in the 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 23S ribosomal RNA and gyrA genes, respectively. A meta-analysis reported high accuracy of these molecular methods for detecting antibiotic resistance in gastric-biopsy samples, with sensitivity and specificity of 96% and 96%, respectively, for clarithromycin resistance and 97% and 99% for quinolone resistance. Learn more in the Review Article “𝘏𝘦𝘭𝘪𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳 𝘱𝘺𝘭𝘰𝘳𝘪 Infection — Advances, Challenges, and the Road Ahead” by Hong Li, MD, PhD, Francis Megraud, MD, and Barry J. Marshall, MD: nej.md/4Bj3O58
8
174
2
591
43,158
Perspective by Nicholas Peoples, MD, Katherine Hoops, MD, JD, MPH, and Eric W. Fleegler, MD, MPH: Mass Surveillance with Artificial Intelligence — A New Determinant of Health? nej.md/4k39Als #AIinMedicine #PublicHealth
3,019
Original Article: Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial (I CAN trial) nej.md/4iwTFdS #Nephrology
3
13
4,309
𝐍𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐢𝐧 𝑵𝑬𝑱𝑴 𝑬𝒗𝒊𝒅𝒆𝒏𝒄𝒆! A new Public Health Alerts report, published in partnership with @CIDRAP: Outcomes among Pregnant Women with Measles and Their Infants in the United States — Preliminary Analysis, 2025–2026 eviden.cc/4zOqTvv
3
2
5
3,229
Correspondence: Interferon-γ Underlying Thymoma-Associated Immune Dysregulation nej.md/3UuLcil #Immunology
1
4
4
4,282
In a new NEJM Voices blog post, Don Dizon, MD, shares how cancer reshapes intimate relationships, challenging couples to find new ways to connect. Read “Sex, Intimacy, Cancer, and Couples” and sign up for email alerts: nej.md/48TiGua
2
3
4,581
A trial of venous thromboembolism (VTE) prophylaxis after hip or knee arthroplasty did not show that aspirin was noninferior to rivaroxaban or warfarin for symptomatic VTE or death. Warfarin and rivaroxaban were not noninferior to aspirin for safety. Full PEPPER trial results and Research Summary: nej.md/4iIxVL0
2
21
2
73
11,232
Presented at #ObesityWeek: In a phase 3, double-blind, randomized trial involving 167 children (6 to <12 years of age) with obesity, treatment with semaglutide resulted in a significantly greater reduction in BMI than placebo. Full STEP Young trial results: nej.md/4ArUURG #OW2026 | @ObesityWeek
11
10
1
32
9,618
A 55-year-old woman presented to the emergency department with a 10-day history of nausea, lightheadedness, and generalized abdominal pain. In the days leading up to her presentation, she had had transient episodes of slurred speech, unsteady gait, and confusion. She also reported a 5-day history of generalized weakness, constipation, polyuria, polydipsia, palpitations, decreased appetite and oral intake, and subjective weight loss. She noted pain in both knees that was consistent with existing chronic joint discomfort. She reported no fevers, chills, cough, chest pain, shortness of breath, dysuria, diarrhea, rashes, or night sweats. How would you proceed with this patient? Test your diagnostic and therapeutic skills: nej.md/4zQuQ2m
1
8
7,841
Resistance threatens existing preventive tools for malaria. Next-generation bed nets are now available, and biologic and genetic approaches show promise. New vaccines offer protection for young children. 🔗 nej.md/4sQ0qLg The fight against malaria is inherently dynamic. The evolutionary imperative warrants the rapid development and implementation of new approaches to keep ahead of the parasite. Sustaining progress — even maintaining current gains — demands relentless effort. Malaria control and prevention is often most needed in remote and economically limited areas and is fragile to disruptions caused by natural disasters, shifts in climate, environmental degradation, human conflict, and economic contraction. Sri Lanka is the salient example of curtailing malaria control, where six indigenous cases in 1963 surged to over half a million within 6 years. Extensive deployment of insecticide-treated nets accounted for 68% of malaria case reduction in Africa between 2000 and 2015. Hence, the increased prevalence of insecticide-resistant vectors has substantially contributed to declining momentum against malaria over the past decade. Likewise, chemoprevention is threatened by the emergence and spread of high-level Plasmodium falciparum resistance to sulfadoxine–pyrimethamine and amodiaquine. On a more positive note, two new classes of insecticide-treated net became available as of 2023, transforming the vector-control space. Seasonal malaria chemoprevention protected 54 million children across 19 countries in sub-Saharan Africa in 2024 (seen in Panel A). In addition, two World Health Organization (WHO)–prequalified malaria vaccines are being deployed across Africa. Learn more in a new review: nej.md/4sQ0qLg
3
10
34
9,856
Original Article: Prasugrel versus Ticagrelor in Acute Coronary Syndromes (SWITCH-SWEDEHEART trial) nej.md/4wGVCZd Editorial: The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome nej.md/45FxURZ #ESCCongress #Cardiology
8
29
132
23,646
In IgA nephropathy, complement activation leads to hematuria, proteinuria, and nephron loss. Does ravulizumab, a terminal complement inhibitor, reduce proteinuria? Research findings from the I CAN trial are summarized in a new Quick Take video. nej.md/4sPRhTf
2
8
45
13,197
After total hip or knee arthroplasty, aspirin alone was noninferior to rivaroxaban followed by aspirin in preventing symptomatic venous thromboembolism, with a similarly low risk of bleeding complications. Full EPCAT III trial results and Research Summary: nej.md/44j0Bne
14
45
3
154
22,271
Zhang and colleagues report autoantibodies neutralizing interferon-α, -ω, and -β in a man who died from H7N7 influenza and mutations in the viral proteins that may facilitate adaptation to humans. Read the full report: nej.md/4iJ84CN
1
13
1
39
16,303
An 81-year-old man transferred to a tertiary-care hospital for pacemaker implantation had a soft, compressible protrusion from the lower posterolateral chest wall on the left side. The protrusion moved inward during inspiration and outward during expiration. Full case details: nej.md/4iGMi2l
4
11
1
75
31,046
A 33-year-old butcher presented with a 3-day history of painful ulcers on his left hand and several hours of worsening arm swelling. Three days before the ulcers appeared, he had slaughtered a sick cow. Read the full case details and submit your answer or see how others responded: nej.md/IC11122026
4
17
4
121
33,825
A 55-year-old woman with hypertension, type 2 diabetes, fibromyalgia, and psoriatic arthritis presented to the emergency department with a 10-day history of nausea, lightheadedness, and abdominal pain. 🔗 nej.md/3UZOZUZ CT-guided core biopsy of the right iliac crest revealed diffuse large B-cell lymphoma, not otherwise specified (seen in figure). Intravenous saline and furosemide were tapered as the calcium level decreased to normal, and symptoms resolved by hospital day 5. The patient started receiving oral ergocalciferol at a dose of 50,000 U weekly for vitamin D deficiency. Transient hypocalcemia developed, which led to the use of intravenous calcium gluconate, oral calcium citrate supplementation, and oral calcitriol. Renal function remained impaired, with a creatinine level of 1.9 mg per deciliter (170 μmol per liter) and an eGFR of 31 ml per minute per 1.73 m². Testing for cryoglobulins, anti–phospholipase A2 receptor antibodies, antinuclear antibodies, and antineutrophil cytoplasmic antibodies was negative, and complement levels were normal. A kidney-biopsy sample showed diffuse nodular diabetic glomerulosclerosis and dense infiltration of the interstitial space by malignant B cells. Read the full case details and authors’ commentary: nej.md/3UZOZUZ
7
33
13,566
Original Article: Prevention of Venous Thromboembolism after Total Hip or Knee Replacement (PEPPER trial) nej.md/4iIxVL0 Editorial: Aspirin Therapy — Enough after Arthroplasty nej.md/3UoXzwn #Surgery #Orthopedics
4
66
1
250
31,241
Whether prasugrel or ticagrelor should be the preferred P2Y12 inhibitor for patients with an acute coronary syndrome is uncertain. Research findings from the SWITCH-SWEDEHEART trial are summarized in a new Quick Take video. nej.md/4ks60ld
5
20
106
27,937
Original Article: Intismeran Autogene plus Pembrolizumab for Resected Stage IIB to IV Melanoma (phase 3 INTerpath-001 trial) nej.md/4sTuIgb Editorial: Cancer Vaccines — From Treatment to Prevention nej.md/3UIPp1K #Oncology #Dermatology
3
16
2
48
15,562
In a new NEJM Voices blog post, Dr. Theodore Iwashyna explains how he decides what matters before rounds. Read “My Pre-Rounding Principles” and sign up for email alerts: nej.md/4C0zY5N
2
9
7,953